Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Not So Fast With Immune Therapy For Breast Cancer
Forbes
Mon, 10/22/18 - 11:14 pm
breast cancer
immunotherapy
Roche
Loxo's targeted therapy holds up to Roche challenge
Biopharma Dive
Sun, 10/21/18 - 11:36 pm
Roche
entrectinib
Loxo Oncology
Ignyta
Bayer
larotrectinib
Benefit of Roche's Tecentriq looks limited in breast cancer
Biopharma Dive
Sat, 10/20/18 - 11:01 pm
Roche
Tecentriq
breast cancer
triple negative breast cancer
Roche leaves Abbott in the dust when it comes to US approval times
EP Vantage
Fri, 10/19/18 - 09:27 am
devices
FDA
device approvals
Roche
Abbott Labs
Becton Dickinson
Roche torches a mountain of biobucks, sweeping out a roster of R&D programs in the latest pipeline cleanup
Endpoints
Wed, 10/17/18 - 09:13 am
Roche
earnings
R&D
RG6125
Actemra
RG7155
Real threat to Opdivo’s small-cell chances will come from elsewhere
EP Vantage
Tue, 10/16/18 - 09:42 am
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
FDA
Tecentriq
Roche
Can Kadcyla give Roche a softer landing when Herceptin biosims hit? New data could help
Fierce Pharma
Mon, 10/15/18 - 11:47 pm
Roche
Kadcyla
Herceptin
BRCA-mutant breast cancer
Roche puts up $125M to expand SQZ cell therapy pact
Fierce Biotech
Mon, 10/15/18 - 12:03 pm
Roche
SQZ Biotech
cell therapy
Pfizer, J&J, Amgen and Roche Start a Bare-Knuckle Brawl Over Biosimilars
BioSpace
Thu, 10/11/18 - 09:38 am
Pfizer
Amgen
Roche
FDA
social media
biosimilars
Roche and Novartis Strengthen Their Presence in the MS Market
BioSpace
Thu, 10/11/18 - 09:35 am
Genentech
Roche
Ocrevus
Novartis
siponimod
FDA
MS
multiple sclerosis
Roche gets option to Ionis' antisense dry AMD candidate
BioCentury
Wed, 10/10/18 - 10:51 pm
Roche
Ionis Pharmaceuticals
IONIS-FB-LRx
antisense
dry age-related macular degeneration
Roche unveils long-term data from MS blockbuster Ocrevus
Pharmaforum
Wed, 10/10/18 - 10:24 am
Roche
Ocrevus
relapsing multiple sclerosis
MS
FDA reviewers endorse Celltrion's Rituxan biosimilar ahead of panel vote
Fierce Pharma
Tue, 10/9/18 - 12:01 pm
Celltrion
Roche
biosimilars
Rituxan
FDA
advisory panels
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom
Xconomy
Thu, 10/4/18 - 06:52 pm
hemophilia A
FDA
Roche
Hemlibra
Trial shows Roche’s new flu drug helps reduce symptoms in at-risk patients
Pharmaforum
Thu, 10/4/18 - 09:46 am
Roche
Flu
influenza
baloxavir marboxil
Roche, Novartis grab FDA OK for new version of aging blockbuster Xolair
Fierce Pharma
Wed, 10/3/18 - 11:49 am
Roche
Novartis
Xolair
Xolair pen
FDA
GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment
CP Wire
Tue, 10/2/18 - 12:02 pm
Roche
Go Therapeutics
drug development
bispecific antibodies
GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment
Tue, 10/2/18 - 09:58 am
Go Therapeutics
Roche
Roche pays €70M upfront for Tusk’s preclinical Treg depleter
Fierce Biotech
Sat, 09/29/18 - 12:03 am
Roche
Tusk Therapeutics
M&A
Tecentriq sets the bar in small-cell lung cancer
Biopharma Dive
Tue, 09/25/18 - 11:08 pm
Roche
Tecentriq
Small-Cell Lung Cancer
Pages
« first
‹ previous
…
42
43
44
45
46
47
48
49
50
…
next ›
last »